What happened
HLB Pharmaceutical updated the terms of a new share issuance to raise US$45.4M, about 14.2% of its market value.
For context, this raise equals about 14.2% of the company's market value, which is the rough scale of potential new-share dilution.
| Instrument | Share issuance |
|---|---|
| Raise amount | US$45.4M |
| vs. market value | 14.2% |
| Filed | 2026-09-08, [Amended] Material event report (rights offering) |
| Source | DART rcept 20260908000180 → open original filing |
Versions of this filing
- 2026-05-13Original
- 2026-06-18Amendment 1
- 2026-08-03Amendment 2
- 2026-09-08Amendment 3 (this page)
Source: DART. Information only, not investment advice.